Home/Filings/4/0001209191-22-038116
4//SEC Filing

Engelson Erik T. 4

Accession 0001209191-22-038116

CIK 0001652724other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 6:45 PM ET

Size

6.9 KB

Accession

0001209191-22-038116

Insider Transaction Report

Form 4
Period: 2022-06-16
Engelson Erik T.
DirectorPresident and Chief Executive
Transactions
  • Purchase

    Common Stock

    2022-06-16$1.49/sh+10,000$14,90063,282 total
Holdings
  • Common Stock

    (indirect: See footnote)
    191,705
  • Common Stock

    (indirect: See footnote)
    46,400
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]The shares are held by the Elisabeth North Kuechler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
  • [F3]The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother

Related Parties

1
  • filerCIK 0001839384

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:45 PM ET
Size
6.9 KB